Paul Tudor Jones’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Paul Tudor Jones’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-21,400	Closed	-$158K	–	1884
2016 Q2	$158K	Sell	21,400 -5,669	-21%	-$42.5K	﹤0.01%	1456
2016 Q1	$173K	Buy	27,069 +7,400	+38%	+$41.5K	﹤0.01%	1536
2015 Q4	$123K	Buy	+19,669	New	+$129K	﹤0.01%	1509
2015 Q3	–	Sell	-13,545	Closed	-$112K	–	1881
2015 Q2	$112K	Sell	13,545 -2,050	-13%	-$18.1K	﹤0.01%	1408
2015 Q1	$129K	Sell	15,595 -11,632	-43%	-$86K	﹤0.01%	1356
2014 Q4	$187K	Buy	+27,227	New	+$170K	0.01%	1290
2014 Q1	–	Sell	-18,432	Closed	-$126K	–	1536
2013 Q4	$126K	Buy	+18,432	New	+$99.5K	0.01%	1182

Other funds holding ARIA

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Paul Tudor Jones's ARIA Position: Q3 2016 in Review

Paul Tudor Jones sold out of Ariad Pharmaceuticals Inc (ARIA) in Q3 2016, closing a stake of 21,400 shares — an estimated $158K sold.

Paul Tudor Jones first reported a position in ARIA in Q4 2013 and held it in 7 quarters. The position peaked at $187K in Q4 2014. 202 funds tracked by Wall St. Rank hold ARIA as of Q3 2016.

Paul Tudor Jones reported no remaining Ariad Pharmaceuticals Inc position as of Q3 2016 after selling out during the quarter.
Paul Tudor Jones sold 21,400 Ariad Pharmaceuticals Inc shares in Q3 2016, an estimated $158K.
Paul Tudor Jones first reported a position in Ariad Pharmaceuticals Inc in Q4 2013 and held it in 7 quarters.
Paul Tudor Jones's Ariad Pharmaceuticals Inc position peaked at $187K in Q4 2014.
202 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q3 2016.

Based on Tudor Investment Corp's 13F filing for Q3 2016, filed 14 Nov 2016.